New on NCI’s Websites for June 2023
Updated: 2023-06-29 00:00:00
NCI periodically provides updates on new websites and other content of interest to the cancer community. See content that has been added as of June 2023.- NCI periodically provides updates on new websites and other content of interest to the cancer community. See content that has been added as of June 2023.
Vorasidenib Treatment Shows Promise for Some Low-Grade Gliomas
Updated: 2023-06-27 00:00:00
In a large clinical trial, vorasidenib slowed the growth of low-grade gliomas that had mutations in the IDH1 or IDH2 genes. Vorasidenib is the first targeted drug developed specifically to treat brain tumors.No Glucose? Pancreatic Cancer May Have a Ready Energy Alternative
Updated: 2023-06-22 00:00:00
A new study finds that pancreatic cancer cells have a ready way to overcome a lack of glucose, a frequent occurrence in this disease. They use another fuel source: a molecule called uridine. Findings from a related study suggest other cancers do as well.How Some Brain Tumors Hijack the Mind to Grow
Updated: 2023-06-21 00:00:00
Researchers have found that the aggressive brain cancer glioblastoma can co-opt the formation of new synapses to fuel its own growth. This neural redirection also appears to play a role in the devastating cognitive decline seen in many people with glioblastoma.Study Identifies Potential Warning Signs of Colorectal Cancer in Younger Adults
Updated: 2023-06-15 00:00:00
Researchers have identified four warning signs that they believe may help identify colorectal cancer early in younger adults. The signs or symptoms are abdominal pain, rectal bleeding, diarrhea, and iron deficiency anemia.Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL
Updated: 2023-06-08 00:00:00
Giving the drug blinatumomab (Blincyto) after standard chemotherapy substantially increased survival for infants with an aggressive form of acute lymphoblastic leukemia (ALL), a recent study showed. If confirmed in larger studies, the treatment may become standard therapy for infants with ALL caused by KMT2A rearrangements.Can Cancer Prevention Be Better Integrated into Primary Care?
Updated: 2023-06-05 00:00:00
When it comes to cancer prevention, primary care clinicians play a critical role. But there are many barriers to integrating cancer prevention into primary care. Researchers are trying to better understand those barriers and how best to overcome them.